Professional Documents
Culture Documents
Apollo said it will also conduct regular medical and quality audits to ensure patient safety
and the best medical outcomes for all patients visiting the hospital.
03
Apollo Hospitals partners with Imperial Hospital, Bangladesh
Apollo Hospitals has entered into a partnership with Imperial Hospital Ltd. (IHL),
Bangladesh, for operations and management of a 375-bed multispeciality tertiary care
hospital, Apollo Imperial Hospitals Ltd., in Chittagong, Bangladesh.
The two hospitals have signed a Brand licensing, Operations and Management (BOMA)
agreement. Apollo Hospitals would manage the day-to-day operations and clinical service
delivery, according to a press release.
Dinesh Madhavan, president, Group Oncology and International, said the hospital was set
up at a cost of over ₹1,000 crore with a direct investment from the World Bank. “Apollo
Hospitals will be operating the facility from July 2022,” he said.
Prathap C. Reddy, founder and chairman of Apollo Hospitals, said patients from
Bangladesh visit Apollo Hospitals in India regularly. Through this partnership, doctors from
Bangladesh would come to India, while doctors from Apollo would visit that country to
augment the medical services, he said.
“Apollo Hospitals has started artificial intelligence (AI), datamatics, robotics and 3D printing.
AI has been rolled out in almost all disciplines. We will take whatever we have to
Bangladesh and will develop for the future,” he said. He later said the patients would not
have to travel out of Bangladesh for a majority of needs.
Mr. Madhavan said secondary care and some tertiary care facilities would be made
available while patients can visit India for liver transplant, robotic surgery, heart-lung
transplant and oncology.
Rabiul Husain, chairman of Imperial Hospital Ltd., said they needed assistance, particularly
in training doctors, nurses and technicians. “The aim is transfer of technology and training of
doctors, nurses and technicians so that treatment can be provided to poor patients who
cannot afford to travel to India,” he said.
Dr. Husain said there were several constraints, particularly in human resource. It was not
easy for patients in Bangladesh to travel abroad.
Mohammed Abdul Malek, board member, IHL, and Harshad Reddy, Director, Operations,
Apollo Proton Cancer Centre, were present.